Tuesday

09-16-2025 Vol 2085

Al Harrington Launches re+PLAY CBD Wellness Brand in Collaboration with Avicanna

SANTA MARTA, Colombia, Sept. 2, 2025 (GLOBE NEWSWIRE) – The re+PLAY CBD wellness brand has officially launched in the United States, following its collaboration with NBA veteran Al Harrington and Avicanna LATAM SAS, an international biopharmaceutical company based in Colombia.

This brand aims to enhance wellness and recovery for athletes through scientifically backed CBD products that prioritize the needs of the athletic community.

The initial offerings include a 3% CBD localized cream and a 2% CBD and 1% CBG transdermal gel, which utilize Avicanna’s proprietary drug delivery technologies.

These products will be available on Harrington Wellness’ website, replaycbd.com, and select retailers across the United States starting this September.

As a business executive and a former professional basketball player, Harrington expressed pride in expanding his collaboration with Avicanna.

“I’m proud to expand our collaboration with Avicanna to introduce this unique and scientifically backed line of CBD wellness products to the United States,” said Harrington, who serves as CEO of Harrington Wellness.

The research and development for re+PLAY involved a collaborative effort among scientists, athletes, doctors, and certified athletic trainers.

These scientifically formulated CBD-based topicals draw from Avicanna’s proprietary formulations and are manufactured using organic hemp-derived cannabinoids sourced from USDA certified farms.

The CBD and CBG utilized in re+PLAY products are derived from Avicanna’s subsidiary, Santa Marta Golden Hemp, and are manufactured by Avicanna LATAM SAS’s team in Colombia.

Avicanna LATAM SAS operates with a strong commitment to the development, manufacturing, and commercialization of plant-derived cannabinoid-based products.

The company has built an established scientific platform that includes more than thirty proprietary, evidence-based finished products across various medical and pharmaceutical sectors.

Their product lines feature multiple delivery methods, including oral, sublingual, topical, and transdermal options supported by ongoing patient and medical community education initiatives.

While their medical cannabis formulary, RHO Phyto™, shows potential, it is important to note that these products are not available in the United States.

In Canada, Avicanna’s subsidiary operates MyMedi.ca, a medical cannabis care platform aimed at optimizing the experience of medical cannabis patients and facilitating their access to a diverse product portfolio.

The product offerings on MyMedi.ca are not intended for the U.S. audience, and similarly, other pharmaceutical products within Avicanna’s pipeline are developed and tested in markets outside the United States.

The collaboration for re+PLAY emphasizes a deep understanding of professional athletes’ needs, facilitated by the expertise of Harrington Wellness and Avicanna LATAM SAS.

The two companies have spent several years dedicated to research and product development tailored specifically for the sports community.

As stated in the product announcement, the re+PLAY brand is designed to target recovery in athletic performance, utilizing a THC-free composition that has gained the endorsement of various professional athletes, trainers, and medical professionals.

In light of the growing interest in CBD products, the launch of re+PLAY represents a convergence of science and athleticism, promising natural support for wellness.

For consumers interested in exploring these offerings, the re+PLAY line emphasizes transparency and quality, delivered through scientifically validated formulations.

However, it is crucial to note that these products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any diseases or conditions.

Potential users are advised to consult a physician before using these products, especially if they have any preexisting medical conditions or are taking prescription medications.

Avicanna LATAM SAS and its parent company, Avicanna Inc., warn that expectations based on forecasting in the business world are subject to variability, and risks must be considered in their endeavors to expand their market presence.

These products are a quintessential step forward in harmonizing the benefits of natural wellness solutions with the specific recovery needs of athletes.

As the popularity of CBD continues to surge, brands like re+PLAY are positioned to meet the demand with scientifically sound products that support the journey of athletes and wellness seekers alike.

image source from:globenewswire

Abigail Harper